These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1791312)

  • 1. Serum levels of ceruloplasmin, properdin factor B and copper in lymphoma patients.
    Casamassima A; Addabbo L; Caporusso L; Lorusso V
    Int J Biol Markers; 1991; 6(3):183-7. PubMed ID: 1791312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum copper, serum ceruloplasmin, and erythrocyte sedimentation rate measurements in children with Hodgkin's disease, non-Hodgkin's lymphoma, and nonmalignant lymphadenopathy.
    Margerison AC; Mann JR
    Cancer; 1985 Apr; 55(7):1501-6. PubMed ID: 3978543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum ceruloplasmin levels in Hodgkin's disease and malignant lymphomas in correlation with serum copper levels.
    Sirsat AV; Raste AS; Talavdekar RV; Advani SH
    Indian J Cancer; 1979 Jun; 16(2):32-4. PubMed ID: 546729
    [No Abstract]   [Full Text] [Related]  

  • 4. Discriminant analysis of Hodgkin's disease and non-Hodgkin's lymphomas by age and serum proteins.
    Merucci P; Taggi F; Marolla A; Abbolito MR; Vitelli G; Marolla P; Meliffi L; Chiarotti F; Ippolito FM; Ameglio F
    Eur J Cancer Clin Oncol; 1984 Oct; 20(10):1243-7. PubMed ID: 6567527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blood copper and ceruloplasmin levels in hemolymphopathies. I. Malignant lymphoma].
    Tura S; Bernardi L; Baccarani M; Sanguinetti F; Branzi A
    G Clin Med; 1968 Nov; 49(11):1090-104. PubMed ID: 5757473
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum copper and zinc levels and copper/zinc ratio in pediatric non-Hodgkin's lymphoma.
    Gözdaşoğlu S; Cavdar AO; Arcasoy A; Akar N
    Acta Haematol; 1982; 67(1):67-70. PubMed ID: 6800204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of sialyltransferase in hypercupraemia of non-Hodgkin's lymphoma.
    Shah I; Chou T; Tapazoglou E; Kessel D
    Scand J Haematol; 1984 Mar; 32(3):332-4. PubMed ID: 6701469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leucocyte zinc in non-Hodgkin's lymphoma and Hodgkin's disease.
    Field HP; Jones R; Walker BE; Kelleher J; Simmons AV
    Nutr Cancer; 1988; 11(2):83-92. PubMed ID: 3362723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum ceruloplasmin levels in patients of leukaemias, Hodgkin's and non-Hodgkin's lymphomas.
    Aggarwal AK; Sanwalka AB; Vadehra PL; Prabhakar BR
    Indian J Pathol Microbiol; 1984 Oct; 27(4):347-52. PubMed ID: 6534868
    [No Abstract]   [Full Text] [Related]  

  • 10. The clinical usefulness of serum copper determinations in Hodgkin's disease. A retrospective study of 241 patients from 1963-1973.
    Thorling EB; Thorling K
    Cancer; 1976 Jul; 38(1):225-31. PubMed ID: 947517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CA 125 elevations in patients with malignant lymphomas.
    Fehm T; Beck E; Valerius T; Gramatzki M; Jäger W
    Tumour Biol; 1998; 19(4):283-9. PubMed ID: 9679739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated serum Cu in Hodgkin's disease and inhibitory effects of ceruloplasmin on lymphocyte response in vitro.
    Larsen B; Heron I; Thorling EB
    Eur J Cancer (1965); 1980 Mar; 16(3):415-21. PubMed ID: 6445273
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum trace elements and Cu/Zn ratio in malignant lymphomas in children.
    Gupta SK; Shukla VK; Gupta V; Gupta S
    J Trop Pediatr; 1994 Jun; 40(3):185-7. PubMed ID: 8078119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical markers in Hodgkin's disease and non-Hodgkin's lymphoma.
    Child JA; Cooper EH; Illingworth S; Worthy TS
    Recent Results Cancer Res; 1978; 64():180-9. PubMed ID: 366696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum copper levels in non-Hodgkin's lymphoma.
    Shah-Reddy I; Khilanani P; Bishop CR
    Cancer; 1980 Apr; 45(8):2156-9. PubMed ID: 6989485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms.
    Kurzrock R; Redman J; Cabanillas F; Jones D; Rothberg J; Talpaz M
    Cancer Res; 1993 May; 53(9):2118-22. PubMed ID: 8481913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged observations on variations in the serum copper in Hodgkin's disease.
    Warren RL; Jelliffe AM; Watson JV; Hobbs CB
    Clin Radiol; 1969 Jul; 20(3):247-56. PubMed ID: 5808043
    [No Abstract]   [Full Text] [Related]  

  • 18. [VARIATIONS IN SERUM COPPER OXIDASE (CERULOPLASMIN) IN THE COURSE OF MALIGNANT LYMPHOGRANULOMATOSIS].
    ZAMFIRESCU-GHEORGHIU M; PETRESCU M; GROZEA P; GOCIU M; SIGHETEA E; VLADESCU C; CUCU F
    Stud Cercet Med Interna; 1964; 5(3):263-7. PubMed ID: 14203689
    [No Abstract]   [Full Text] [Related]  

  • 19. Ceruloplasmin in Hodgkin's disease.
    Koprivová H; Dienstbier Z; Sámal M; Foltýnová V
    Neoplasma; 1982; 29(3):333-40. PubMed ID: 7133228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum L-selectin and P-selectin levels in lymphomas.
    Haznedaroglu IC; Benekli M; Ozcebe O; Savaş MC; Güllü IH; Dündar SV; Kirazli S
    Haematologia (Budap); 2000; 30(1):27-30. PubMed ID: 10841321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.